Product Information
VERAPAMIL ER 180 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1930 per EA under NDC 68462029301. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
180 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462029301
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090700On Market Since
8/5/2011
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 180 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 19.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1930 per EA |
|---|---|
| All-time high | $0.2281 (Apr 15, 2020) |
| All-time low | $0.1191 (Jan 23, 2019) |
| 52-week high | $0.1940 |
| 52-week low | $0.1781 |
| Median price | $0.1800 |
| Average price | $0.1772 |
| Largest weekly change | +22.6% (Feb 20, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 180 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1930 per EA (NDC 68462029301), effective Jun 24, 2026.
How has the price of VERAPAMIL ER 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 180 MG TABLET has risen 19.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 180 MG TABLET?
Since Nov 28, 2013, the NADAC for VERAPAMIL ER 180 MG TABLET has ranged from a low of $0.1191 (Jan 23, 2019) to a high of $0.2281 (Apr 15, 2020), with a median of $0.1800 per EA.
Are there cheaper alternatives to VERAPAMIL ER 180 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as VERAPAMIL ER 180 MG TABLET, but none are currently priced below it.
Who manufactures VERAPAMIL ER 180 MG TABLET?
VERAPAMIL ER 180 MG TABLET (NDC 68462029301) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification